[
    "This sample is a phase 2 clinical trial for HER-2 overexpressing breast cancer, testing the efficacy of trastuzumab, docetaxel, and carboplatin in a dose dense regimen, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with gastroesophageal reflux disease, testing the effectiveness of ilaprazole and esomeprazole in treating symptoms, with specific eligibility criteria and exclusion criteria listed.",
    "This sample is a phase 2 trial testing the drug thalidomide in patients with peritoneal carcinomatosis or adenomucinosis secondary to colorectal or appendiceal cancer who have undergone cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IPHC) within the past 12 weeks, and meet various eligibility criteria.",
    "This sample is a phase 2 clinical trial for sodium nitrite in patients with peripheral arterial disease, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial testing the drug tki258 in patients with advanced/metastatic scirrhous gastric carcinoma, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the drug bremelanotide, targeting female sexual arousal disorder and hypoactive sexual desire disorder, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial testing the drugs methylnaltrexone bromide and placebo for the treatment of opioid-induced constipation in participants who have undergone orthopedic procedures and are expected to require daily opioid analgesics for at least 7 days post-randomization.",
    "This phase 2 trial aims to evaluate the efficacy of tiotropium bromide, placebo, and salmeterol xinafoate in patients with asthma who are homozygous for arginine at the 16th amino acid position of the beta2 adrenergic receptor, have a documented history of asthma, and are on a maintenance treatment with inhaled corticosteroids.",
    "This sample is a phase 2 trial for patients with hormone-resistant, recurrent, or stage IV prostate cancer, testing the drug saracatinib, with specific eligibility criteria including previous treatment with docetaxel, ECOG performance status 0-1, and various laboratory and medical condition requirements.",
    "This sample is a phase 2 trial testing the effectiveness of sublingual methadone in treating breakthrough pain in cancer patients, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer, testing two interventions: irinotecan, oxaliplatin, and neulasta, and etoposide, carboplatin, and neulasta, with specific eligibility criteria and exclusion criteria.",
    "This phase 2 trial is testing the drug sorafenib tosylate in patients with recurrent or stage IIIB/IV non-small cell lung cancer, who meet specific eligibility criteria including measurable disease, performance status, blood counts, liver and kidney function, and no prior immunotherapy or chemotherapy for NSCLC.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC), testing the drug cetuximab. The eligibility criteria include having histologically confirmed NSCLC, measurable disease, normal organ and marrow function, and willingness to use contraception. Exclusion criteria include prior chest radiation therapy, history of pulmonary fibrosis, and severe allergic reactions to certain medications.",
    "This sample is a phase 2 trial for patients with metastatic or advanced/unresectable kidney cancer, testing the effectiveness of gefitinib as a treatment option, with specific eligibility criteria and restrictions on concurrent therapies.",
    "This sample is a phase 1/phase 2 trial for esophageal cancer, testing the drugs cisplatin and fluorouracil, with eligibility criteria including histologically confirmed carcinoma, resectable disease, and specific patient characteristics.",
    "This sample is a phase 2 trial testing the drug taranabant on smokers who smoke at least 10 cigarettes a day for at least 1 year, with inclusion criteria including laboratory tests and overall good health, and exclusion criteria including psychiatric diagnoses, certain cancers, nicotine replacement therapy use, and patients on a diet regimen.",
    "This sample is a phase 2 trial for chronic obstructive pulmonary disease (COPD) patients, testing the effectiveness of different doses of a drug on improving symptoms, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for non-Hodgkin's lymphoma patients who are HBsAg-positive, and it involves the use of cyclophosphamide, epirubicin, etoposide, and prednisolone as the chemotherapy regimen. The eligibility criteria include no previous chemotherapy or radiotherapy, specific blood count and liver function requirements, and signed informed consent. Exclusion criteria include age restrictions, pregnancy or breastfeeding, brain metastasis or CNS involvement, liver cirrhosis, impaired cardiac function, and concurrent use of glucocorticoids.",
    "This sample is a phase 2 trial for inoperable estrogen receptor positive and HER2 negative breast cancer, testing the drugs pd 0332991 and letrozole, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for breast cancer patients, testing the effectiveness of pemetrexed and gemcitabine drugs, with specific eligibility criteria including performance status, prior chemotherapy, and measurable disease.",
    "This sample is a phase 2 trial testing the drug olaparib on patients with ovarian, breast, prostate, pancreatic, and advanced tumors who have confirmed BRCA mutations and no standard treatment options available.",
    "This sample is a phase 2 trial for the treatment of psoriasis vulgaris using daivobet gel applied for different durations, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the efficacy and safety of octohydroaminoacridine succinate tablets compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with type 1 diabetes, testing the effectiveness of liraglutide compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the effectiveness of palonosetron and granisetron in reducing nausea and vomiting in patients receiving moderately emetogenic chemotherapy or cisplatin. The eligibility criteria include age, disease status, previous chemotherapy experience, and predicted life expectancy.",
    "This sample is a phase 2 trial for patients with metastatic or unresectable colon cancer who have progressed on cetuximab plus irinotecan based combination, and it aims to evaluate the efficacy of cetuximab with irinotecan as a treatment option.",
    "This sample is a phase 2 clinical trial for patients with hepatocellular carcinoma, testing the effectiveness of a combination of etoposide, oxaliplatin, and capecitabine as a treatment option. The eligibility criteria include specific disease characteristics, age range, normal organ function, and no recent chemotherapy or radiotherapy.",
    "This sample is a phase 2 trial for patients with mild persistent asthma, testing the effectiveness of bdp/formoterol and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with advanced soft tissue sarcoma, testing the drug lbh589 (panobinostat\u00ae) as a potential treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with schizophrenia, testing the drugs tc-5619 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with moderate to severe chronic plaque psoriasis, testing the effectiveness of drugs including placebo, rg3421 120mg, and rg3421 20mg, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of refractory neuropathic pain in patients with advanced or recurrent cancer, using the drugs krn5500 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for the treatment of schizophrenia using the drugs vabicaserin and risperidone, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer, testing the effectiveness of docetaxel/carboplatin/bevacizumab/erlotinib and docetaxel/carboplatin drugs as treatment options, with specific eligibility criteria for patient selection.",
    "This sample is a phase 2 clinical trial for ovarian neoplasms, testing the combination of sagopilone and carboplatin as a treatment option, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2 clinical trial for patients with primary central nervous system lymphoma, testing the drug pemetrexed, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for psoriasis vulgaris, testing the drugs leo 22811 and placebo, with inclusion criteria such as a clinical diagnosis of psoriasis vulgaris, a Psoriasis Area and Severity Index (PASI) score of \u226510, and disease severity of moderate, severe, or very severe. Exclusion criteria include recent systemic treatments and other skin conditions that may confound the evaluation of psoriasis vulgaris.",
    "This phase 2 trial is investigating the efficacy of docetaxel, liposomal doxorubicin, and enoxaparin in patients with histologically-confirmed pancreatic cancer, who have locally-advanced unresectable disease or metastatic disease, and meet specific eligibility criteria.",
    "This sample is a phase 2 trial for functional dyspepsia, testing the drug z-338, with inclusion criteria based on Rome II diagnosis and the most bothersome symptom being postprandial fullness and/or early satiety.",
    "This sample is a phase 2 trial for diabetes, testing the drugs phentermine/topiramate and placebo, with inclusion criteria including completion of a previous trial and written informed consent, and exclusion criteria including the development of morbidities during the previous trial.",
    "This sample is a phase 2 clinical trial for patients with histologically verified epithelial ovarian cancer, using gemcitabine, carboplatin, and paclitaxel as drugs, with specific inclusion and exclusion criteria.",
    "This phase 2 trial is investigating the efficacy of [s,s]-reboxetine and placebo in treating painful, distal, symmetrical, sensory-motor polyneuropathy caused by diabetes, with inclusion criteria including a minimum pain score on the Visual Analogue Scale and exclusion criteria such as significant hepatic impairment and unrelated neurological disorders.",
    "This sample is a phase 2 clinical trial testing the effectiveness of oxycodone and oxycodone/naloxone in treating constipation induced or worsened by opioid medication in cancer patients, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for participants with type 2 diabetes mellitus, testing the effectiveness of the drugs mk-0893, sitagliptin, and metformin, as well as their respective placebos, in improving glucose control.",
    "This sample is a phase 2/phase 3 trial for patients with metastatic breast cancer, testing the drug capecitabine. The inclusion criteria include patients with previous treatment or no previous treatment with anthracyclines and/or taxanes, ambulatory patients with a functional ECOG < 2 status, and patients with at least one measurable lesion according to RECIST criteria. The exclusion criteria include patients with previous severe reactions to fluoropyrimidines or known sensitivity to 5-fluorouracil, patients previously treated with capecitabine, patients with organ transplants, and patients with certain diseases or severe affections such as convulsions, central nervous system diseases, psychiatric diseases, severe intellectual impairment, clinical significant cardiac disease, severe renal impairment, active infection, history of other neoplasias, and abnormal laboratory values.",
    "This sample is a phase 2 clinical trial for patients with relapsing-remitting multiple sclerosis (RRMS) and multiple sclerosis (MS). The trial is testing the effectiveness of dimethyl fumarate in patients who have been taking a prescribed IFN\u03b2 or GA for at least 12 months. The inclusion criteria include a confirmed diagnosis of RRMS, specific MRI findings, and an Expanded Disability Status Scale (EDSS) between 0.0 and 5.0. The exclusion criteria include other types of MS, other chronic diseases, pregnancy or nursing, and recent participation in other studies.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the effectiveness of dexamethasone and bortezomib as treatment options. The eligibility criteria include having measurable disease, prior chemotherapy, and specific performance status and creatinine clearance levels. Certain exclusions apply, such as previous bortezomib treatment and peripheral neuropathy.",
    "This sample is a phase 2 clinical trial for patients with metastatic or advanced gastric cancer, testing the drug trastuzumab in patients with HER2 overexpression, who have had disease progression after prior chemotherapy.",
    "This sample is a phase 1/phase 2 trial for high-risk hematologic malignancies, including acute leukemia, myelodysplastic syndromes, Hodgkin's lymphoma, non-Hodgkin's lymphoma, myeloma, and chronic myelogenous leukemia, using fludarabine, thiotepa, and melphalan as drugs, with specific eligibility criteria and donor selection requirements.",
    "This sample is a phase 2 trial for allergic rhinitis, testing the drugs placebo, allegra, allegra-d, and pf-03654746, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with polycythemia vera, testing the drug erlotinib, and includes specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 trial for patients diagnosed with breast or gynecological cancer, testing the effectiveness of fosaprepitant dimeglumine, 5-ht3 ra, dexamethasone, and rescue medication in reducing chemotherapy-induced nausea and vomiting.",
    "This sample is a phase 2 clinical trial for patients with melanoma, testing the effectiveness of sorafenib tosylate and temsirolimus as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This phase 2 trial is investigating the efficacy of memantine hydrochloride (HCl) and placebo capsules in treating various autism spectrum disorders, including autistic disorder, autism, and Asperger's disorder, in children aged 6 to 12 years who have completed a lead-in study and met specific eligibility criteria.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer patients, testing the effectiveness of carboplatin, vinorelbine, and panitumumab in combination, with specific eligibility criteria including histological confirmation of metastatic NSCLC, wild type KRAS, BRAF, and PI3K genes, and adequate organ function.",
    "This sample is a phase 2 trial for patients with stable coronary artery disease, testing the drugs ticagrelor, clopidogrel, and aspirin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the drugs retapamulin and placebo for the treatment of bacterial infections, specifically targeting Staphylococcus aureus in the nasal area, with various inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2 clinical trial for patients with chronic lymphocytic leukemia, testing the effectiveness of bendamustine and rituximab as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with aggressive non-Hodgkin's lymphoma, testing the effectiveness of rituximab, etoposide, methylprednisolone, cytarabine, and cisplatin as a second-line chemotherapy treatment. The eligibility criteria include a clinical diagnosis of aggressive non-Hodgkin's lymphoma, refractory or relapsed disease, expression of CD20 on lymphoma cells, and measurable lesions on imaging studies.",
    "This sample is a phase 2 clinical trial for patients with lung cancer, testing the effectiveness of oxaliplatin and pemetrexed drugs in combination with eligibility criteria including prior treatment history, disease measurements, performance score, and adequate organ function.",
    "This sample is a phase 2 trial for rheumatoid arthritis patients who have been receiving methotrexate treatment for at least 6 months, and the study will test the effectiveness of the drugs azd5672, etanercept, and placebo in reducing symptoms.",
    "This sample is a phase 2 trial testing the drug edoxaban (du-176b) and warfarin in patients with atrial fibrillation and thromboembolism, who meet specific inclusion criteria such as having persistent non-valvular AF supported by abnormal ECG and a CHADS2 index score of at least 2, and excluding those with mitral valve disease or contraindications to anticoagulants.",
    "This sample is a phase 1/phase 2 trial for patients with various hematological malignancies, who are scheduled for hematopoietic stem cell transplantation from unrelated donors and currently receiving a conditioning regimen. The study aims to evaluate the safety and efficacy of methotrexate, sirolimus, and tacrolimus as part of the treatment. The eligibility criteria include specific disease characteristics, donor compatibility requirements, and various patient characteristics such as age, performance status, and organ function.",
    "This sample is a phase 2 trial for patients with essential hypertension, testing the drug pl3994 against a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with gastroesophageal reflux disease (GERD), testing the effectiveness of rabeprazole and low dose tricyclic antidepressant in reducing GERD symptoms in patients currently being treated with a PPI but still experiencing symptoms at least 2 times per week.",
    "This sample is a phase 2 clinical trial for patients with esophageal cancer, testing the effectiveness of carboplatin and pemetrexed drugs in combination, with specific eligibility criteria for patients to be included in the study.",
    "This phase 2 trial is testing the drug erlotinib hydrochloride for the treatment of fallopian tube cancer, primary peritoneal cavity cancer, recurrent ovarian epithelial cancer, and stage IV ovarian epithelial cancer, with specific eligibility criteria for patient selection.",
    "This sample is a phase 1/phase 2 trial for amyotrophic lateral sclerosis (ALS) patients, testing the efficacy of zinc and copper as a treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with breast cancer, testing the effectiveness of a combination of drugs including doxorubicin hydrochloride, cyclophosphamide, paclitaxel, tamoxifen citrate, and aromatase inhibition therapy, with specific eligibility criteria for patients to be included in the trial.",
    "This sample is a phase 2 trial testing the drugs esomeprazole and placebo in adults with asthma and gastroesophageal reflux disease (GERD), with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the effectiveness of fimasartan, amlodipine, and placebo in treating essential hypertension patients with specific blood pressure criteria, while excluding patients with severe hypertension, secondary hypertension, abnormal renal or liver function, hypokalemia or hyperkalemia, and other medical conditions.",
    "This sample is a phase 2 trial for patients with type 2 diabetes, testing the drugs mci-196 and placebo of mci-196 tablet, with inclusion criteria based on fasting blood glucose levels and HbA1c, and exclusion criteria related to cardiac, hepatic, renal, and diabetic complications, as well as pregnancy and contraception.",
    "This sample is a phase 2 trial for patients with proliferative diabetic retinopathy and macular edema, testing the effectiveness of ranibizumab in reducing foveal thickness and macular volume post PRP therapy.",
    "This sample is a phase 2 trial for the treatment of metastatic adenocarcinoma of the pancreas using the drugs gsk1120212, gemcitabine, and placebo, with specific eligibility criteria and exclusion criteria.",
    "This phase 2 trial is testing the drug eribulin mesylate in patients with various stages of prostate cancer, including hormone-refractory and recurrent disease, who have previously undergone hormonal therapy and have evidence of treatment failure. The study aims to assess the efficacy and safety of eribulin mesylate in this patient population.",
    "This sample is a phase 1/phase 2 clinical trial for the drug tak-700 in male patients with metastatic prostate adenocarcinoma, testing its efficacy and safety based on specific eligibility criteria.",
    "This sample is a phase 2 clinical trial testing the drugs sirolimus, mycophenolate mofetil, carmustine, etoposide, cyclophosphamide, and ftbi for the treatment of various hematologic diseases, including leukemia, lymphoma, and myelodysplastic syndrome, in patients aged 2 to 60 years. The eligibility criteria include specific age ranges, disease types, and performance status, among others.",
    "This sample is a phase 2 trial for patients with locally advanced rectal adenocarcinoma, testing the effectiveness of capecitabine, fluorouracil, leucovorin calcium, and oxaliplatin as pre-operative chemoradiation therapy. The eligibility criteria include specific tumor characteristics, performance status, and various laboratory values.",
    "This sample is a phase 2 trial for lupus nephritis, testing the effectiveness of mycophenolate sodium, prednisone, and methylprednisolone in patients who meet specific inclusion criteria and do not meet certain exclusion criteria.",
    "This sample is a phase 2 trial for patients with gastroesophageal reflux disease (GERD) and related symptoms, testing the drug lesogaberan (azd3355) against a placebo, with specific inclusion and exclusion criteria for enrollment.",
    "This sample is a phase 2/phase 3 trial testing the drug sodium valproate for the treatment of neuralgia and neuropathic peripheral pain, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with anaplastic thyroid carcinoma, testing the drug imatinib, with specific eligibility criteria including measurable disease, stable brain metastases, age 18 or older, Karnofsky performance status >70%, and normal hematologic and hepatic function.",
    "This sample is a phase 2 clinical trial for patients with chronic hepatitis C, testing the efficacy of various drugs including copegus placebo, ro5024048, danoprevir, peginterferon alfa-2a (pegasys), ribavirin (copegus), and ritonavir, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for pancreatic cancer, testing the drug vorinostat, and includes eligibility criteria such as ECOG performance status, tumor staging, and organ function requirements.",
    "This sample is a phase 2 clinical trial for patients with Sj\u00f6gren's syndrome, testing the drug rebamipide to alleviate symptoms of dry mouth and decreased salivation.",
    "This sample is a phase 2 clinical trial for prostate cancer patients, testing the drugs docetaxel and zd1839, with specific eligibility criteria including clinical stage, PSA levels, Gleason score, ECOG performance status, and adequate organ function.",
    "This sample is a phase 2 clinical trial for ovarian cancer, testing the effectiveness of two drug combinations (genexol\u00ae-pm 260mg/m2 plus carboplatin 5 auc and genexol\u00ae 175mg/m2 plus carboplatin 5 auc) on patients with unresectable or metastatic epithelial cancer of the exocrine pancreas. The eligibility criteria include being 18 years or older and having written informed consent, while exclusion criteria include prior radiation therapy or systemic treatment for pancreatic cancer.",
    "This sample is a phase 2 clinical trial for postherpetic neuralgia, testing the effectiveness of retigabine and placebo in reducing pain in patients with PHN for more than 6 months after the healing of herpes zoster skin rash.",
    "This sample is a phase 2 trial for patients with prostate cancer that is unresponsive to hormone therapy, testing the drugs pi-88, docetaxel, and prednisone, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the drugs pf-04494700 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with stage IIIB or IV non-small cell lung cancer who have progressed after treatment with erlotinib. The trial will test the efficacy of erlotinib hydrochloride, pemetrexed disodium, and docetaxel as potential treatments for lung cancer.",
    "This sample is a phase 2 clinical trial for patients with gout and moderate renal insufficiency, testing the efficacy of ulodesine (bcx4208) at two different doses compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with extensive stage small cell lung cancer, testing the effectiveness of carboplatin, etoposide, and topotecan hydrochloride as treatment options. The eligibility criteria include age 18 and over, ECOG performance status 0-2, and various medical requirements.",
    "This sample is a phase 2 clinical trial testing the drugs talactoferrin alfa and placebo in patients with severe sepsis, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for children with attention deficit hyperactivity disorder (ADHD), testing the effectiveness of extended release methylphenidate (ritalin la) plus behavior therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the effectiveness of peramivir and placebo in treating acute, uncomplicated human influenza, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for nicotine dependence, testing the drug gw468816 against a placebo comparator, with inclusion criteria including smoking 10 or more cigarettes per day, DSM-IV criteria for nicotine dependence, and willingness to quit smoking, and exclusion criteria including pregnancy, severe medical illness, and history of non-response to nicotine replacement therapy.",
    "This sample is a phase 2/phase 3 trial for patients diagnosed with schizophrenia, testing the efficacy of three different doses of the drug mp-214. The inclusion criteria include obtaining written informed consent, meeting the DSM-IV-TR criteria for schizophrenia, and having normal physical examination, laboratory, vital signs, and/or ECG results. The exclusion criteria include patients with schizoaffective disorder, schizophreniform disorder, other psychotic disorders other than schizophrenia, or bipolar I or II disorder.",
    "This sample is a phase 2/phase 3 trial for patients with unipolar depression, testing the effectiveness of escitalopram and pindolol as treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with anal cancer, testing the effectiveness of fluorouracil and mitomycin c drugs in combination with eligibility criteria including specific disease characteristics and patient characteristics.",
    "This sample is a phase 2 clinical trial for patients with Parkinson's disease, testing the efficacy of the drugs azd3241 and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer patients, testing the efficacy of pemetrexed and gemcitabine plus bevacizumab as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with colorectal cancer and unresectable liver metastasis, testing the effectiveness of bevacizumab, capecitabine, and oxaliplatin in combination, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with recurrent or metastatic gastric cancer, testing the drugs olaparib, paclitaxel, and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with unresectable metastatic colorectal cancer, testing the effectiveness of capecitabine, fluorouracil, irinotecan hydrochloride, and leucovorin calcium as treatment options, with specific eligibility criteria for patient selection.",
    "This sample is a phase 2 trial for patients with moderate COPD, testing the effectiveness of different doses of the drug pf-03635659 compared to a placebo and an active comparator, with specific inclusion and exclusion criteria.",
    "This phase 2 trial is testing the drug temozolomide in participants with metastatic colorectal cancer, recurrent or metastatic head & neck or esophageal cancer, or locally advanced, inoperable, or metastatic non-small cell lung cancer, who have a positive biomarker test, up to a certain number of prior regimens, and meet other eligibility criteria.",
    "This sample is a phase 2 trial for patients with metastatic esophageal cancer, testing the drugs ecf, ic, and folfox, with eligibility criteria including histologic documentation of squamous cell or adenocarcinoma, availability of tumor EGFR status, and stable weight.",
    "This sample is a phase 2 clinical trial for knee osteoarthritis, testing the drugs crx-102, prednisolone, and placebo, with eligibility criteria including age, knee pain, radiographic evidence of knee OA, and functional class, while excluding certain medical conditions and medications.",
    "This sample is a phase 2 clinical trial testing the drug imatinib mesylate for the treatment of systemic sclerosis, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 1/phase 2 trial for kidney transplantation, kidney disease, and kidney failure, using drugs such as alemtuzumab, mycophenolate mofetil, sirolimus, and tacrolimus, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for HIV infections, testing the drugs matching placebo and bevirimat, with eligibility criteria including documented HIV-1 infection, specific genotypic resistance mutations, and stable antiretroviral therapy regimen.",
    "This sample is a phase 2 trial for patients with atherosclerosis, testing the drugs mldl1278a, placebo, and statin, stable dose, to evaluate the efficacy of reducing plaque inflammation in qualifying vessels, with specific inclusion and exclusion criteria.",
    "This phase 2 clinical trial aims to evaluate the efficacy of teriflunomide and placebo in patients with multiple sclerosis, based on specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for hypertension, testing the drugs mk8141 and enalapril, with eligibility criteria including age, medication history, and exclusion criteria including certain medical conditions and participation in other clinical studies.",
    "This sample is a phase 2 trial for the treatment of allergic rhinitis, testing the drugs placebo, mk-8237 6 du, and mk-8237 12 du, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with various types of ovarian cancer, testing the drug cediranib maleate, and includes eligibility criteria such as prior therapy, normal lab values, and exclusion criteria such as recent chemotherapy or major surgery.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of capecitabine, bevacizumab, and irinotecan as second-line therapy after FOLFOX/AVASTIN, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for the drug aplidin (plitidepsin) in patients with myelofibrosis, a type of blood cancer, who have not responded to other treatments. The study aims to assess the safety and efficacy of the drug in eligible patients based on specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic or recurrent colorectal cancer, testing the drug bortezomib. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for the treatment of glaucoma and ocular hypertension, testing the drugs ama0076 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with acute myeloid leukemia (AML) who are at least 60 years old and fit for intensive chemotherapy. The trial aims to evaluate the effectiveness of azacitidine and lenalidomide as treatment options. The inclusion criteria include confirmed AML diagnosis, high-risk features, poor risk cytogenetics, and life expectancy of more than 1 month. Exclusion criteria include prior therapy with azacitidine or lenalidomide, uncontrolled infection, and certain medical conditions.",
    "This sample is a phase 2 trial for patients with triple-receptor-negative metastatic or relapsed breast cancer, testing the efficacy of endotag-1 + paclitaxel, endotag-1, and paclitaxel as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial testing the drug GSK1363089 (formerly xl880) on patients with advanced or metastatic gastric carcinoma or adenocarcinoma of the gastroesophageal junction or distal esophagus, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for children with recurrent or progressive high-grade glioma, testing the drug cilengitide, and includes eligibility criteria such as histologically confirmed primary CNS high-grade glioma, radiographically documented measurable disease, and specific laboratory values.",
    "This sample is a phase 2 trial for patients with non-small-cell lung carcinoma, testing the drug xl647 for those with progressive disease following prior treatment with erlotinib or gefitinib, or those with a T790M EGFR mutation. The study has specific inclusion and exclusion criteria, and patients must have measurable disease and an ECOG performance status of 0 or 1.",
    "This sample is a phase 2 trial for patients with hypercholesterolemia, testing the effectiveness of atorvastatin and aegr-733 in reducing LDL-C levels, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 clinical trial for the treatment of psoriasis using the drug cnto 1959, adalimumab, and placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 1/phase 2 clinical trial for patients with non-small cell lung cancer, testing the drug abi-007, with eligibility criteria including advanced stage IV NSCLC, no prior chemotherapies for metastatic disease, and specific baseline laboratory values.",
    "This sample is a phase 1/phase 2 trial for the drug rp-1127 (glyburide for injection) in patients with acute ischemic stroke, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with locally advanced and/or metastatic pancreatic cancer, testing the combination of erlotinib and gemcitabine as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for metastatic colorectal cancer, testing the effectiveness of chemotherapy (capecitabine, oxaliplatin, 5-fu, leucovorin) in patients with no prior treatment for metastatic disease, PS 0-2, and measurable disease, while excluding patients with neuropathy grade 2 or higher, concomitant radiation therapy or other systemic cancer therapies, and brain metastases.",
    "This sample is a phase 2 trial for rheumatoid arthritis patients who have an inadequate response to methotrexate, and the study will test the efficacy of drugs such as methotrexate and adalimumab, along with their placebos, as potential treatments.",
    "This sample is a phase 2 trial for patients with non-small-cell lung carcinoma or adenocarcinoma, testing the drug Velcade as a treatment option for those who have progressed on prior chemotherapy, including an EGFR TKI.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma and plasma cell neoplasm, testing the effectiveness of dexamethasone, lenalidomide, and melphalan as treatment options. The eligibility criteria include confirmed multiple myeloma, ineligibility for stem cell transplantation, and measurable serum M-component or urinary excretion of light-chain protein. Patients must also meet certain patient characteristics, such as ECOG performance status, life expectancy, and blood counts. Prior concurrent therapy restrictions apply, and patients must not have certain medical conditions or history of cardiac dysfunction.",
    "This sample is a phase 2 trial for the treatment of human immunodeficiency virus (HIV) infection using a combination of drugs including bms-663068, raltegravir, tenofovir, ritonavir, and atazanavir, with specific inclusion and exclusion criteria.",
    "This phase 2 trial is testing the drug E7389 in patients with advanced and/or metastatic malignant soft tissue sarcoma of various histologies, who have relapsed, refractory, and/or metastatic disease incurable by surgery or radiotherapy, and have evidence of objective progression within the last 6 months.",
    "This sample is a phase 1/phase 2 clinical trial testing the drug CP-4055, both as a single agent and in combination with idarubicin, for the treatment of relapsed/refractory leukemias, specifically AML. The eligibility criteria include having no standard therapies available, being 18 years or older, having an ECOG performance status of 0-2, and meeting certain laboratory values. The exclusion criteria include allergies to similar compounds, positive HIV or hepatitis status, pregnancy or nursing, uncontrolled illness, and receiving other cytotoxic treatments.",
    "This sample is a phase 2 clinical trial for patients with metastatic and/or unresectable adenocarcinoma of the prostate, testing the effectiveness of docetaxel, ly2181308 sodium, and prednisone in hormone refractory prostate cancer patients with specific eligibility criteria.",
    "This sample is a phase 2 trial for patients with metastatic breast cancer, testing the combination of bevacizumab and paclitaxel as a treatment option, with specific eligibility criteria including age, cancer stage, HER2 status, and previous chemotherapy history.",
    "This sample is a phase 2 clinical trial for patients with head and neck cancer, testing the effectiveness of lapatinib, a drug used in the treatment of breast cancer, in combination with concurrent chemoradiotherapy. The eligibility criteria include specific disease stage, absence of distant metastasis, and certain medical parameters.",
    "This sample is a phase 2 clinical trial for patients with moderate to severe chronic obstructive pulmonary disease (COPD), testing the efficacy of indacaterol/glycopyrrolate and indacaterol compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for insomnia, with the disease being primary insomnia and the drugs being pd 0200390 and placebo. The inclusion criteria include a 3-month history of primary insomnia and difficulty initiating and maintaining sleep, while the exclusion criteria include any history of an Axis 1 psychiatric diagnosis and any breathing related sleep disorder.",
    "This sample is a phase 2 trial for major depressive disorder, testing the efficacy of quetiapine extended release (xr) compared to placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for subjects with type 2 diabetes mellitus, testing the drugs p2202 and placebo, with inclusion criteria including BMI, duration of diabetes, glycemic control, and stable doses of metformin and/or sulfonylurea. Exclusion criteria include type 1 diabetes, history of severe hypoglycemia, and recent use of certain medications.",
    "This sample is a phase 2 trial for the treatment of eosinophilic esophagitis using the drug qax576 and its placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for patients with advanced or metastatic breast cancer who have failed previous treatments, and it aims to evaluate the efficacy of the drug MKC-1 in this population. The eligibility criteria include specific disease characteristics, prior treatment history, and certain laboratory values.",
    "This sample is a phase 1/phase 2 trial that focuses on patients with various types of germ cell tumors, including brain and central nervous system tumors, extragonadal germ cell tumor, ovarian cancer, teratoma, and testicular germ cell tumor. The study aims to evaluate the effectiveness of carboplatin, ifosfamide, and paclitaxel in treating advanced disease that is resistant to cisplatin-based chemotherapy. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy requirements.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic colorectal carcinoma, testing the drugs su011248, irinotecan, and cetuximab, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with relapsed or refractory acute myelogenous leukemia (AML) or acute lymphoblastic leukemia (ALL) with minimal residual disease (MRD), testing the effectiveness of drugs such as clofarabine, cytarabine intravenous, methotrexate, and intrathecal cytarabine, with eligibility criteria including age, diagnosis, ANC and platelet counts, performance level, prior therapy, renal and hepatic function, cardiac function, reproductive function, and exclusion criteria such as previous HSCT, previous treatment with clofarabine, CNS2 or CNS3 disease, Down Syndrome, veno-occlusive disease, uncontrolled infections, use of investigational agents, concomitant therapy, pregnancy or lactation, concurrent diseases or psychiatric disorders, previous malignancy, and active acute or chronic extensive GVHD.",
    "This sample is a phase 2 trial for adult attention deficit hyperactivity disorder (ADHD) using the drugs sep-225289 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for castrate resistant prostate cancer and chemotherapy naive prostate cancer, testing the drugs pasireotide and everolimus, with specific eligibility criteria for patients to be included or excluded from the study.",
    "This phase 2 trial is testing the effectiveness of sorafenib (nexavar, bay43-9006) compared to a placebo in patients with refractory solid cancer, specifically carcinoma, renal cell, who have failed curative or palliative measures, have no other treatment options, and meet specific eligibility criteria.",
    "This sample is a phase 2 trial for the treatment of hepatitis C, using the drugs grazoprevir and ribavirin, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 1/phase 2 trial for patients with acute lymphoblastic leukemia, testing the drug native l asparaginase. The inclusion criteria include being between 1 and 55 years old, having relapsed after first remission, or being refractory to first-line chemotherapy for ALL.",
    "This sample is a phase 2 trial for menopausal women with symptoms of estrogen and/or androgen deficiency, testing the effectiveness of esterified estrogens and methyltestosterone in controlling these symptoms.",
    "This sample is a phase 2 trial for patients with moderate to severe ulcerative colitis, testing the effectiveness of anti-ip-10 antibody compared to placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with testicular cancer who have relapsed after previous chemotherapy treatment, and it aims to evaluate the effectiveness of paclitaxel, cisplatin, and gemcitabine in treating the disease. The eligibility criteria include histologically confirmed germ cell tumor, previous treatment with standard BEP, male gender, age 18 or older, specific performance status and blood count requirements, adequate renal function, and signed informed consent. Exclusion criteria include uncontrolled severe infection, concomitant systemic disorders, peripheral neuropathy, and second malignancy.",
    "This sample is a phase 2 trial for patients with constipation caused by opioid use, testing the effectiveness of the drugs placebo and adl5945 0.25 mg in improving bowel movements and other symptoms, with specific eligibility criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with metastatic colon or rectal cancer, testing the effectiveness of bevacizumab (Avastin) as a second-line treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for the treatment of overactive bladder, testing the drugs uk-369,003 and placebo, with inclusion criteria including male subjects aged 18 years and above and a clinical diagnosis of overactive bladder with specific frequency and urgency episodes, while excluding subjects with neurological diseases affecting bladder function and urinary tract infection.",
    "This sample is a phase 2 clinical trial for patients with T-cell prolymphocytic leukemia (T-PLL) testing the drug velcade, with specific inclusion and exclusion criteria for enrollment in the study.",
    "This sample is a phase 2 clinical trial for patients with multiple sclerosis, testing the effectiveness of alemtuzumab, fludarabine, and cyclophosphamide as a treatment option, with specific eligibility criteria including age, diagnosis, HIV status, EDSS score, and previous treatment failure.",
    "This sample is a phase 2 trial for the drug ralfinamide in patients with neuropathic pain, with inclusion criteria including being diagnosed by a neurologist and exclusion criteria being the same as the inclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with colorectal cancer and metastases, testing the effectiveness of bevacizumab, capecitabine, and irinotecan as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with HER2-positive invasive breast cancer, testing the effectiveness of everolimus as a treatment option, with specific eligibility criteria and patient characteristics outlined.",
    "This sample is a phase 2 clinical trial for patients with sickle cell anemia or sickle \u00df0-thalassemia, testing the effectiveness of l-glutamine and placebo in reducing the frequency of painful crises, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for patients with chronic obstructive pulmonary disease (COPD) and aims to evaluate the efficacy of aclidinium/formoterol combination therapy compared to placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial investigating the use of placebo and peginesatide in patients with anemia, chronic kidney disease, and chronic renal failure, who meet specific eligibility criteria.",
    "This sample is a phase 2 clinical trial for patients with recurrent glioblastoma multiforme, testing the effectiveness of pazopanib hydrochloride as a treatment option, with specific eligibility criteria and restrictions on prior therapies and medical conditions.",
    "This sample is a phase 2 clinical trial for patients with relapsed mantle cell lymphoma, testing the effectiveness of bortezomib and gemcitabine hydrochloride as treatment options, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 2 trial for previously untreated Hodgkin lymphoma patients, testing various chemotherapy regimens, and includes eligibility criteria such as age, disease stage, and prior treatment history.",
    "This sample is a phase 2 trial investigating the use of epoetin alfa in patients with myocardial infarction, with specific inclusion and exclusion criteria outlined.",
    "This phase 2 trial is investigating the efficacy of saracatinib in patients with estrogen receptor-negative and progesterone receptor-negative breast cancer, who have unresectable, locally advanced or metastatic disease, and have failed one line of chemotherapy for metastatic disease.",
    "This sample is a phase 2/phase 3 trial for anaplastic thyroid cancer, testing the drugs ca4p, paclitaxel, and carboplatin, with specific eligibility criteria for patients to be included or excluded from the study.",
    "This sample is a phase 2 trial for patients with myelodysplastic syndrome (MDS) and the drugs being tested are antithymocyte globulin (atg) and prednisone. The eligibility criteria include a diagnosis of MDS that meets specific criteria, a certain performance status score, and willingness to attend study visits and use contraception.",
    "This phase 2 trial is testing the drug alvocidib in patients with refractory multiple myeloma, with specific eligibility criteria including prior therapy regimens, performance status, blood counts, liver and kidney function, and exclusion of other medical conditions or active malignancies.",
    "This sample is a phase 1/phase 2 clinical trial for patients with locally advanced inoperable or metastatic adenocarcinoma of the pancreas or biliary tract. The trial aims to evaluate the efficacy and safety of oxaliplatin, capecitabine, and sorafenib as systemic treatment options.",
    "This phase 2 trial is investigating the efficacy of dasatinib, a kinase inhibitor, in patients with small cell lung cancer (SCLC) who have experienced disease progression or recurrence after initial platinum-based chemotherapy, and have measurable disease.",
    "This sample is a phase 2 clinical trial for breast cancer patients, testing various drug combinations including doxorubicin and cyclophosphamide, docetaxel, and bevacizumab, with eligibility criteria including age, tumor size, lymph node status, and cardiac function.",
    "This sample is a phase 2 clinical trial testing the effectiveness of solifenacin succinate, tamsulosin hydrochloride, and placebos in treating lower urinary tract symptoms and bladder outlet obstruction, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for amyotrophic lateral sclerosis (ALS) patients, testing the drug memantine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with metastatic colorectal cancer, testing the effectiveness of the drugs ngr-htnf, oxaliplatin, and capecitabine, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with breast cancer, testing the drug sunitinib, and includes eligibility criteria such as histologically proven diagnosis, metastatic or locally recurrent disease, and exclusion criteria such as inflammatory breast cancer and prior treatment with VEGF inhibitors.",
    "This sample is a phase 2 clinical trial for the treatment of chemotherapy-induced nausea and vomiting, using the drugs gw679769, dexamethasone, and ondansetron hydrochloride, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for postmenopausal women with breast adenocarcinoma, testing the effectiveness of tamoxifen and everolimus in combination for metastatic disease, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with critical lower limb ischemia, testing the effectiveness of the drugs Hemospan (mp4ox) and Voluven (hes 130/0.4) in improving blood pressure and circulation, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for patients with nonseminoma germ cell tumor, testing the effectiveness of carboplatin, cisplatin, etoposide phosphate, and vincristine sulfate as treatment options, with specific eligibility criteria for patients including certain disease characteristics and patient characteristics.",
    "This sample is a phase 2 clinical trial for patients with squamous cell carcinoma of the head and neck (SCCHN), testing the effectiveness of bevacizumab, erlotinib, and sulindac as treatment options, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for the treatment of chronic hepatitis C virus (HCV) infection using the drugs abt-267, pegylated interferon (pegIFN), and ribavirin (RBV), with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with non-small-cell lung carcinoma and adenocarcinoma, testing the effectiveness of bevacizumab, carboplatin, paclitaxel, and axitinib in treating advanced lung cancer. The inclusion criteria include having advanced non-squamous cell lung cancer and no prior treatment for lung cancer, while the exclusion criteria include prior therapy for advanced lung cancer, the need for blood-thinners, and coughing up blood.",
    "This sample is a phase 2 trial for heart failure patients, testing the drug ck-1827452 against a placebo, with eligibility criteria including a documented diagnosis of heart failure and stable use of beta blockers and ACE inhibitors or ARBs.",
    "This sample is a phase 2 trial for the treatment of chronic hepatitis C, testing the drugs ach-0141625 (sovaprevir), placebo, pegylated interferon alpha-2a, and ribavirin, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 trial for patients with newly diagnosed stage I and II nasal Natural Killer (NK) cell lymphoma, testing the effectiveness of cyclophosphamide, doxorubicin, vincristine, and prednisone as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for high-risk Ewing's family of tumors, specifically Ewing's sarcoma, and it includes eligibility criteria such as age range, performance status, and hematopoietic requirements. The drugs being tested in this trial are cyclophosphamide, dexrazoxane hydrochloride, disaccharide tripeptide glycerol dipalmitoyl, doxorubicin hydrochloride, and vincristine sulfate.",
    "This sample is a phase 2 clinical trial for patients with leptomeningeal carcinomatosis and non-small cell lung cancer, testing the drug erlotinib. The eligibility criteria include age >18, confirmed diagnosis of NSCLC and leptomeningeal carcinomatosis, EGFR mutation, ECOG performance status 0-3, and previous chemotherapy-na\u00efve status.",
    "This sample is a phase 2 clinical trial for breast cancer patients, testing the drug taxotere, with eligibility criteria including female gender, locally advanced or primary breast cancers, negative pregnancy test, kidney and liver function within normal limits, performance status < 2, age > 18, and no brain or leptomeningeal disease.",
    "In this sample, the phase 2 trial is focused on lung neoplasm (non-small cell lung cancer) and the drug being tested is vinorelbine. The inclusion criteria include inoperable stage IIIA N2 or IIIB NSCLC, absence of malignant pleural effusion, performance status =1, and a life expectancy of at least 12 weeks. The exclusion criteria include metastatic disease, small cell lung carcinoma, prior chemotherapy or radiotherapy, resectable tumor, unstable systemic disease, and any other malignancies within 5 years.",
    "This sample is a phase 2 clinical trial for the treatment of seasonal allergic rhinitis using drugs such as act-129968, cetirizine, and placebo, with specific inclusion and exclusion criteria for participants.",
    "This phase 2 trial aims to evaluate the efficacy of goserelin acetate, letrozole, anastrozole, and chemotherapy in treating estrogen receptor-positive breast cancer, her2-negative breast cancer, and stage II-III breast cancer patients who meet specific eligibility criteria.",
    "This sample is a phase 2 trial for patients with locally advanced or metastatic non-small cell lung carcinoma, testing the drugs pemetrexed and pemetrexed + pf-3512676, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with locoregionally confined stage III or IV squamous cell carcinoma of the head and neck region, testing the effectiveness of cisplatin, fluorouracil, and iressa as treatment options.",
    "This sample is a phase 2 clinical trial for postmenopausal women with locally advanced or metastatic breast cancer, testing the efficacy of letrozole monotherapy in reducing CA 15-3 levels by at least 50% from baseline, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with hormone-refractory metastatic prostate cancer, testing the effectiveness of docetaxel, estramustine phosphate sodium, and isotretinoin as treatment options. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy requirements.",
    "This sample is a phase 2 trial for relapsing remitting multiple sclerosis, testing the effectiveness of drugs such as natalizumab, interferon beta 1-a, methylprednisolone, and glatiramer acetate, with specific eligibility criteria including a diagnosis of relapsing MS and prior treatment with natalizumab.",
    "This sample is a phase 1/phase 2 trial for the treatment of hepatitis C, using the drugs bavituximab and pegylated interferon, with specific eligibility criteria including age, HCV genotype, HCV RNA level, and normal hematology and chemistry variables.",
    "This sample is a phase 1/phase 2 clinical trial for individuals with inherited erythromelalgia, testing the effectiveness of the drug xpf-001 compared to a placebo in reducing pain levels, with various inclusion and exclusion criteria for participation.",
    "This sample is a phase 2 clinical trial for patients with follicular non-Hodgkin lymphoma, testing the efficacy of a combination of cyclophosphamide, doxorubicin hydrochloride, prednisolone, and vincristine sulfate as a treatment option for relapsed disease. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy requirements.",
    "This sample is a phase 2 trial for HIV infections, testing the effectiveness of multiple drugs including abacavir sulfate, emtricitabine, lamivudine, lopinavir/ritonavir, saquinavir, tenofovir disoproxil fumarate, and zidovudine, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for prostate cancer patients, testing the drug Zometa, with eligibility criteria including a histologic diagnosis of adenocarcinoma of the prostate, detectable PSA levels, and an ECOG performance status of <2.",
    "This sample is a phase 2 clinical trial for patients with moderate to severe chronic plaque psoriasis, testing the effectiveness of the drugs act-128800 and placebo. The eligibility criteria include age range, exclusion of other forms of psoriasis and autoimmune disorders, and exclusion of patients with ongoing infections or history of malignancy.",
    "This sample is a phase 2 clinical trial for Crohn's disease, testing the drug \"vehicle control\" on subjects who have failed previous treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for esophageal cancer, testing the effectiveness of cisplatin, gefitinib, and paclitaxel as treatment options, with specific eligibility criteria for patients to participate in the study.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the drugs sb-742457, donepezil, and placebo, with specific inclusion and exclusion criteria for subjects.",
    "This phase 2 trial is testing the drug belinostat for the treatment of various types of myelodysplastic syndromes, including de novo, previously treated, and secondary MDS, and has specific eligibility criteria for patients to participate in the study.",
    "This sample is a phase 2 trial for patients with Alzheimer's disease, testing the drug leuprolide acetate, and includes eligibility criteria such as age, diagnosis, medication history, cognitive function, and caregiver involvement.",
    "This sample is a phase 2 clinical trial testing the drug everolimus for the treatment of various types of relapsed or refractory lymphoma, including aggressive lymphoma, indolent lymphoma, and uncommon lymphoma. The eligibility criteria include having previously treated disease, measurable disease, and specific patient characteristics such as Eastern Cooperative Oncology Group performance status 0-2 and adequate blood counts.",
    "This sample is a phase 2 clinical trial for Crohn's disease, testing the effectiveness of ciprofloxacin and metronidazole in patients with specific inclusion and exclusion criteria.",
    "This phase 2 trial aims to evaluate the effectiveness of paclitaxel, carboplatin, and erlotinib in treating patients with various types of ovarian and peritoneal cancers, who have undergone appropriate surgery and meet specific eligibility criteria.",
    "This sample is a phase 2 trial for breast cancer patients, testing the drug rad 001, with specific eligibility criteria including performance status, age, disease progression, and adequate organ function.",
    "This sample is a phase 2 trial for Alzheimer's disease, testing the drug rosiglitazone, and includes eligibility criteria such as completion of a previous treatment phase, post-menopausal status or contraceptive use for female subjects, and informed consent from both the subject and caregiver.",
    "This sample is a phase 2 clinical trial for the treatment of diabetic macular edema using ranibizumab, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC) testing the combination of celecoxib and docetaxel as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with metastatic colorectal adenocarcinoma, testing the effectiveness of cetuximab and lenalidomide in combination therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the drug jnj-26489112 and placebo in patients with photosensitive epilepsy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for bladder cancer, testing the effectiveness of cisplatin, doxorubicin hydrochloride, methotrexate, and vinblastine sulfate in treating transitional cell carcinoma of the bladder with muscle invasion suitable for resection, with specific eligibility criteria for patients.",
    "This sample is a phase 2 clinical trial for patients with myelodysplastic syndromes (MDS) who meet specific eligibility criteria, including being in low or intermediate-1 IPSS risk group, having anemia, and not being eligible for high intensity therapies. The drug being tested is metoclopramide.",
    "This sample is a phase 2 trial for patients with hepatocellular carcinoma, testing the efficacy of infusional 5-fluorouracil and sorafenib in treating inoperable tumors, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with locally advanced-unresectable or metastatic pancreatic cancer, testing the drugs erlotinib and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with stage IV malignant melanoma, testing the drug abt-510, with specific eligibility criteria including no known potentially curative standard therapy, measurable disease, and certain patient characteristics.",
    "This sample is a phase 2 trial testing the use of azacitadine and hematopoietic growth factors in patients with myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML), refractory anemia (RA), or refractory anemia with ringed sideroblasts (RARS). The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 trial for patients with rectal cancer, testing the effectiveness of intensified preoperative chemotherapy in patients with T3/4 or node positive disease, who are considered resectable or potentially resectable after preoperative chemoradiation.",
    "This sample is a phase 2 trial testing the efficacy and safety of PS433540 in treating hypertension, with irbesartan, placebo, and PS433540 as the drugs being studied, and the inclusion criteria including specific blood pressure ranges and contraceptive use for women of child-bearing potential.",
    "This sample is a phase 2 clinical trial for patients with myelodysplastic syndrome, testing the efficacy of decitabine as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for the treatment of urinary tract infections (UTIs) using the drugs gsk2251052 and imipenem-cilastatin, with specific eligibility criteria including age, contraception methods, and UTI symptoms.",
    "This sample is a phase 2 clinical trial for patients with metastatic renal cell carcinoma and neoplasm metastases, testing the effectiveness of gemcitabine and sunitinib as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast cancer, testing the effectiveness of docetaxel, carboplatin, herceptin, and vinorelbine as chemotherapy agents, with specific eligibility criteria including HER-2 overexpression and adequate organ function.",
    "This sample is a phase 2 clinical trial for the treatment of migraine, testing the effectiveness of ketorolac tromethamine and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the drugs eplerenone and losartan for patients with mild to moderate hypertension, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for individuals with type 2 diabetes mellitus, testing the efficacy of two different formulations of metformin (efb0027 and efb0026) in combination with DPP-4 inhibitors, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with ovarian cancer, testing the efficacy of bortezomib and pegylated liposomal doxorubicin as treatment options, with specific eligibility criteria including prior chemotherapy limits, performance status, age range, and adequate organ function.",
    "This sample is a phase 2/phase 3 trial that aims to evaluate the effectiveness of aspirin, clopidogrel, and simvastatin in patients with transient ischemic attack (TIA) or stroke, who are not eligible for acute thrombolysis or other acute interventions. The eligibility criteria include age 40 or older, specific neurological deficits, and a time window for randomization within 24 hours of symptom onset. The exclusion criteria include certain types of symptoms, contraindications for trial medication, and participation in other clinical trials.",
    "This phase 2 trial aims to evaluate the efficacy of palifermin, placebo, and methotrexate in combination with conditioning therapy for allogeneic stem cell support in subjects with hematologic malignancies, including graft versus host disease, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with colorectal cancer and metastatic cancer, testing the effectiveness of fluorouracil, leucovorin calcium, and oxaliplatin in combination with surgical resection of liver metastases. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the efficacy of two drugs, pt001 mdi and ipratropium bromide hfa inhalation aerosol, in improving lung function and symptoms. The study includes specific inclusion and exclusion criteria, such as age range, smoking history, and lung function measurements.",
    "This sample is a phase 2 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of insulin glargine as basal insulin, with inclusion criteria such as BMI range, HbA1C level, and exclusion criteria including allergies to study drugs and use of certain medications.",
    "This sample is a phase 2/phase 3 trial for patients with metastatic breast cancer, testing the effectiveness of drugs such as g-csf, trastuzumab, and vinorelbine, with specific eligibility criteria including confirmation of breast carcinoma, HER-2/neu overexpression, and adequate cardiac function.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer, testing the effectiveness of cisplatin, docetaxel, and pegfilgrastim as chemotherapy treatments. The eligibility criteria include specific disease stages, no prior treatment, and certain health parameters. Exclusion criteria include known allergies to certain drugs and inability to comply with protocol procedures.",
    "This sample is a phase 2 trial for cytomegalovirus infections, testing the use of a placebo drug in patients awaiting a liver or kidney transplant, with specific inclusion and exclusion criteria.",
    "This phase 2 trial is testing the drug perifosine in patients with metastatic or recurrent squamous cell cancer of the head and neck who are not eligible for surgery or radiotherapy, and have no known brain metastases.",
    "This sample is a phase 2 clinical trial for idiopathic pulmonary fibrosis, testing the drugs placebo and bibf 1120, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 2 trial aims to evaluate the efficacy of sofosbuvir, placebo to match sofosbuvir, peg, and rbv in treating chronic genotype 1, 2, or 3 hepatitis C virus (HCV) infection in males and females aged 18 to 70 years, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with chronic lymphocytic leukemia, testing the combination of valproic acid and fludarabine as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with colorectal cancer, testing the drugs cpt-11 and ts-1, as well as cpt-11, 5-fu, and l-lv, with specific eligibility criteria including prior chemotherapy, no prior irinotecan administration, and certain health parameters.",
    "This sample is a phase 2 clinical trial for patients with recurrent de novo or transformed diffuse large B cell lymphoma, testing the effectiveness of sorafenib tosylate as a treatment option. The eligibility criteria include specific disease types, performance status, prior treatment history, and various laboratory values.",
    "This sample is a phase 2 trial for patients with foot ulcers and diabetes complications, testing the effectiveness of the drugs mre0094 and vehicle gel in treating the ulcers. The eligibility criteria include having type 1 or type 2 diabetes mellitus, nerve problems in the feet, and a large ulcer present for at least 3 weeks.",
    "This sample is a phase 2 trial testing the effectiveness of tanezumab and placebo in treating neoplasm metastasis and palliative care patients with bone pain caused by prostate cancer, breast cancer, renal cell carcinoma, or multiple myeloma.",
    "This sample is a phase 1/phase 2 trial for hormone refractory prostate cancer, testing the drugs picoplatin and docetaxel, with eligibility criteria including confirmed adenocarcinoma of the prostate, metastatic disease, and stable pain levels.",
    "This sample is a phase 2 clinical trial for patients with stage IIIB non-small cell lung cancer (NSCLC), testing the effectiveness of cisplatin and etoposide as treatment options, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 2 clinical trial for patients with schizophrenia, testing the effectiveness of armodafinil and placebo as treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with advanced non-small cell lung cancer, testing the efficacy of erlotinib and docetaxel as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for ovarian cancer patients with platinum-resistant disease, testing the efficacy of vintafolide and pegylated liposomal doxorubicin (PLD) as treatment options, with specific eligibility criteria including prior debulking surgery and a measurable lesion on radiological evaluation.",
    "This sample is a phase 2 clinical trial for the treatment of ulcerative colitis using the drugs aeb071 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This phase 2 trial is testing the drug vorinostat for the treatment of adult giant cell glioblastoma, adult glioblastoma, adult gliosarcoma, and recurrent adult brain tumor, with specific eligibility criteria including histological confirmation, measurable disease, performance status, blood counts, liver and kidney function, and absence of certain medical conditions.",
    "This sample is a phase 2/phase 3 trial for hypertension, testing the effectiveness of olmesartan medoxomil and placebo in patients with high blood pressure, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with prostate cancer, testing the effectiveness of aminoglutethimide, ketoconazole, and therapeutic hydrocortisone as treatment options, with specific eligibility criteria outlined.",
    "This sample is a phase 1/phase 2 trial for patients with melanoma, testing the combination of gleevec and temozolomide as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with platinum-resistant epithelial ovarian carcinoma and peritoneal neoplasms. The trial will test the effectiveness of docetaxel and gemcitabine as a treatment option. The eligibility criteria include having measurable or evaluable disease, being over 18 years old, and meeting certain performance and blood count requirements.",
    "This sample is a phase 2 clinical trial for breast cancer patients with HER2 over-expression, testing the drug neratinib, and includes specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 clinical trial for patients with locally advanced or metastatic pancreatic cancer, testing the combination of erlotinib hydrochloride and gemcitabine hydrochloride as a potential treatment option. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 trial for patients with hormone-resistant or recurrent prostate cancer, testing the drug saracatinib, and includes eligibility criteria such as prior chemotherapy, disease progression, castration status, and various laboratory values.",
    "This sample is a phase 2 clinical trial for the treatment of migraine, with the drugs being tested including ast-726 low dose, ast-726 high dose, and ast-726 placebo, and the eligibility criteria including having migraine headaches according to International Headache Society guidelines and having 2 to 10 attacks per month.",
    "This sample is a phase 2/phase 3 trial for patients with ocular hypertension, testing the drug bimatoprost to lower intraocular pressure (IOP) in both eyes, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of hepatitis C virus (HCV) using the drugs daclatasvir, simeprevir, and ribavirin, with specific eligibility criteria including HCV genotype, age, HCV RNA levels, liver condition, and exclusion criteria such as liver transplant, other medical conditions, HIV or hepatitis B infection, gastrointestinal disease, uncontrolled diabetes or hypertension, prior exposure to HCV direct-acting agents, and various blood test results.",
    "This sample is a phase 2/phase 3 trial for patients with Parkinson's disease, testing the effectiveness of pramipexole immediate release and pramipexole extended release in improving symptoms and addressing therapeutically problematic issues associated with L-DOPA therapy. The inclusion criteria include patients with a diagnosis of PD, onset at age 40 or younger, and a modified Hoehn and Yahr scale of II to IV at \"on\" time. The exclusion criteria include atypical parkinsonian syndromes, dementia, psychiatric disorders, history of psychosis, clinically significant ECG abnormalities, hypotension, other clinically significant diseases, pregnancy or breastfeeding, and certain abnormal serum levels.",
    "This sample is a phase 2/phase 3 trial testing the effectiveness of levetiracetam and lorazepam in treating seizures, with inclusion criteria of having seizures and exclusion criteria of pregnancy, renal failure, and hepatic impairment.",
    "This sample is a phase 2 trial for the drug tak-875 in patients with type 2 diabetes mellitus, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for gastric cancer, testing the effectiveness of cisplatin, fluorouracil, leucovorin calcium, and paclitaxel as treatment options, with specific eligibility criteria for patients to be included in the study.",
    "This sample is a phase 1/phase 2 trial for patients with systemic sclerosis, testing the effectiveness of imatinib in combination with eligibility criteria including fulfilling ACR criteria for SSc, having dyspnea on exertion, and showing evidence of alveolitis.",
    "This sample is a phase 2/phase 3 trial for restless legs syndrome, testing the effectiveness of rasagiline and placebo in patients with moderate or severe symptoms, who are not currently receiving treatment for RLS and meet specific inclusion criteria.",
    "This sample is a phase 2/phase 3 clinical trial for rheumatoid arthritis, testing the drugs sarilumab, placebo (for sarilumab), methotrexate, and folic acid, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with unresectable metastatic or recurrent colorectal cancer, testing the effectiveness of capecitabine and oxaliplatin as treatment options, with specific eligibility criteria for patients to participate in the trial.",
    "This phase 2 trial is investigating the efficacy of celecoxib and letrozole in postmenopausal women with locally advanced or metastatic breast cancer, who have histologically confirmed adenocarcinoma and hormone receptor-positive status.",
    "This sample is a phase 2 trial for patients with breast cancer, specifically recurrent or stage IV breast cancer, testing the drug pazopanib hydrochloride. The eligibility criteria include no prior bevacizumab treatment, measurable disease, specific blood counts and liver function, no brain metastases, and various other medical conditions.",
    "This sample is a phase 2 trial for rheumatoid arthritis patients who have had an inadequate response to methotrexate or leflunomide, and it will test the efficacy of mlta3698a, adalimumab, leflunomide, methotrexate, and placebo as potential treatments.",
    "This sample is a phase 2 clinical trial for the treatment of geographic atrophy, a form of macular degeneration, using the drugs al-78898a and sham injection. The eligibility criteria include a confirmed diagnosis of bilateral geographic atrophy, specific visual acuity requirements, and exclusion of certain eye conditions and medical history.",
    "This sample is a phase 2 trial for depressive disorder, testing the drugs gsk372475, venlafaxine, and placebo, with inclusion criteria including major depressive episode and exclusion criteria including current diagnosis of panic disorder or other psychiatric disorders.",
    "This sample is a phase 2 clinical trial for patients with acute myeloid leukemia (AML) or acute lymphoblastic leukemia (ALL), testing the effectiveness of clofarabine and cytarabine as treatment options. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy requirements.",
    "This sample is a phase 2 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of ly2605541 and insulin glargine in combination with metformin and/or sulfonylurea(s) in controlling blood glucose levels.",
    "This sample is a phase 2 trial for asthma patients, testing the effectiveness of various drugs including formoterol fumarate dpi and mometasone furoate/formoterol fumarate mdi, with specific eligibility criteria such as a minimum duration of asthma diagnosis and stable daily dose of inhaled corticosteroids.",
    "This sample is a phase 2 clinical trial that aims to test the effectiveness of cisplatin and paclitaxel in treating various types of cancer, including ovarian, primary peritoneal, cervical, and fallopian tube carcinoma, uterine sarcoma, and endometrial adenocarcinoma. The eligibility criteria include specific disease characteristics, age, performance status, hematopoietic, hepatic, renal, and cardiovascular conditions, as well as prior concurrent therapies.",
    "This sample is a phase 2 trial for the treatment of postherpetic neuralgia, using levetiracetam as the drug, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for glaucoma and ocular hypertension, testing the effectiveness of latanoprost, ar-12286 ophthalmic solution, and timolol maleate ophthalmic solution in reducing intraocular pressure, with specific eligibility criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with prostate adenocarcinoma, testing the effectiveness of drugs such as bicalutamide and ipilimumab, with eligibility criteria including confirmed adenocarcinoma, specific PSA levels, and adequate organ function.",
    "This sample is a phase 2 clinical trial for patients with advanced hepatobiliary carcinoma, including gallbladder cancer, cholangiocarcinoma, liver cancer, and hepatocellular carcinoma. The drug being tested is becatecarin, and the eligibility criteria include measurable disease, specific age and performance status requirements, and certain hematopoietic, hepatic, renal, and cardiovascular conditions. Prior chemotherapy for cholangiocarcinoma or hepatobiliary carcinoma is not allowed.",
    "This sample is a phase 2 clinical trial for cervical cancer patients with specific tumor characteristics, testing the effectiveness of bevacizumab and carboplatin as concurrent chemotherapy drugs, with detailed inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with uncontrolled epilepsy, testing the effectiveness of intravenous immunoglobulin (IVIG) as a treatment option. The inclusion criteria include a diagnosis of uncontrolled epilepsy, age between 18 and 50, and refractory to multiple anti-epileptic drugs. The exclusion criteria include a history of certain medical conditions and evidence of psychogenic epilepsy.",
    "This sample is a phase 2 trial for patients with HIV infections, testing the effectiveness of raltegravir potassium, darunavir/ritonavir, etravirine, and an optimized background regimen in patients with specific protease inhibitor and reverse transcriptase mutations.",
    "This sample is a phase 2 trial for patients with ischemic heart disease, testing the efficacy of CK-1827452 and placebo in improving symptoms such as exercise-induced angina, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of capecitabine, oxaliplatin, and bevacizumab in combination, with specific eligibility criteria for inclusion in the study.",
    "This sample is a phase 2 clinical trial testing the drug aripiprazole for the treatment of autism spectrum disorders, specifically autistic disorder, Asperger syndrome, and autism spectrum disorder. The eligibility criteria include age range, diagnosis criteria, and exclusion criteria such as previous trial of aripiprazole and significant chronic medical illness.",
    "This sample is a phase 2 clinical trial for patients with uterine cancer, testing the drug celecoxib, a COX-II inhibitor, to measure its effects on tumor types and disease status, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with relapsed or refractory multiple myeloma, testing the effectiveness of perifosine, bortezomib, and dexamethasone as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for posttraumatic stress disorder (PTSD) patients, testing the effectiveness of nepicastat and placebo drugs on individuals who have served in OIF/OEF or Afghanistan conflicts or other Southwest Asia conditions, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with nasal polyposis and asthma, testing the effectiveness of omalizumab compared to a placebo, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 trial for asthma patients, testing the drugs bi671800 and fluticasone placebo, with eligibility criteria including a history of reversible asthma, no previous use of ICS, and an ACQ score of at least 1.5.",
    "This sample is a phase 2 clinical trial for patients with non-small-cell lung carcinoma, testing the drug erlotinib in African American patients who have previously been treated with 1-2 platinum- or taxane-containing regimens, and have measurable disease.",
    "This sample is a phase 2 clinical trial for patients with metastatic or unresectable melanoma, testing the effectiveness of sorafenib tosylate and temozolomide as treatment options, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 2 trial for patients with poorly controlled Type 2 diabetes, testing the drugs pf-00734200 and placebo, with inclusion criteria of men and women between 18-80 years of age, and exclusion criteria of Type 1 or secondary forms of diabetes and current use of insulin.",
    "This phase 2 trial aims to evaluate the efficacy of the drugs ppd10558 and atorvastatin, along with a placebo, in patients with myalgia, hypercholesterolemia, and hyperlipidemia, who have a history of statin-associated myalgia and meet specific inclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the effectiveness of palonosetron, an antiemetic drug, in preventing chemotherapy-induced nausea and vomiting.",
    "This sample is a phase 2 trial for patients with metastatic melanoma or skin cancer, testing the effectiveness of cyclophosphamide and fludarabine phosphate in combination with other eligibility criteria such as age, disease status, and serology.",
    "This sample is a phase 2 trial for patients with Parkinson's disease, testing the drugs preladenant and placebo tablet, with eligibility criteria including a diagnosis of idiopathic PD, prior therapy with L-dopa, stable dopaminergic treatment regimen, and experiencing motor fluctuations.",
    "This sample is a phase 2 trial for asthma patients, testing the drugs gw642444m and placebo, with eligibility criteria including age, gender, contraceptive use, asthma diagnosis, and use of inhaled corticosteroids.",
    "This sample is a phase 2 clinical trial for previously untreated patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), testing the effectiveness of cyclophosphamide and pentostatin as chemotherapy drugs, with specific eligibility criteria for patient selection.",
    "This sample is a phase 2 trial for patients with refractory epilepsy, testing the drug clonazepam, with inclusion criteria of a diagnosis of refractory epilepsy and no nasal conditions that would preclude the use of intranasal product, and exclusion criteria of a subject with a clinically significant unstable medical abnormality and a subject currently or regularly taking clonazepam.",
    "This sample is a phase 1/phase 2 trial that focuses on patients with diseases such as leukemia, lymphoma, neuroblastoma, immunodeficiencies, and anemia. The trial involves the use of drugs like alemtuzumab, melphalan, busulfan, phenytoin, fludarabine, cyclophosphamide, horse antithymocyte globulin, rabbit antithymocyte globulin, and thiotepa. The eligibility criteria include specific requirements for renal, liver, cardiac, and pulmonary function, as well as the absence of certain conditions like pregnancy or uncontrolled infection.",
    "This sample is a phase 2 trial for patients with locally advanced or metastatic papillary or follicular thyroid carcinoma, testing the drug vandetanib, and includes eligibility criteria such as confirmed histological diagnosis, presence of measurable lesions, and progressive disease following RAI131 or patient unsuitability for RAI131 after surgery.",
    "This sample is a phase 2 trial for patients with progressive metastatic prostate cancer, testing the drugs carboplatin and paclitaxel, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with recurrent non-small cell lung carcinoma and stage IIIB/IV non-small cell lung cancer. The study will test the effectiveness of pemetrexed disodium and sunitinib malate as second-line therapy for patients who have progressed after first-line treatment. The eligibility criteria include specific histologic documentation, tumor stage, prior treatment regimens, and various medical conditions that may affect patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with unresectable urothelial carcinoma of the bladder or upper urinary tract, testing the effectiveness of gemcis + panitumumab and gemcis drugs in combination, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial studying the effectiveness of lapatinib and pazopanib in treating patients with breast neoplasms, specifically inflammatory breast cancer, who have had disease progression or relapse following treatment for invasive breast cancer. The eligibility criteria include specific requirements for disease confirmation, ErbB2 overexpression, organ function, and contraception use.",
    "This sample is a phase 2 clinical trial for patients with aggressive non-Hodgkin's lymphoma, testing the effectiveness of a combination of drugs including cyclophosphamide, doxorubicin hydrochloride, prednisone, and vincristine sulfate, with specific eligibility criteria based on disease characteristics and patient characteristics.",
    "This sample is a phase 2 clinical trial for patients with prostate cancer, specifically targeting those with androgen-independent PSA-progressive disease or docetaxel-resistant metastatic disease. The drug being tested is enzastaurin, and the eligibility criteria include age, previous treatments, and organ function.",
    "This sample is a phase 2 clinical trial for breast neoplasms, testing the effectiveness of a combination of drugs including docetaxel, doxorubicin, carboplatin, cyclophosphamide, trastuzumab, and bevacizumab, with specific eligibility criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with relapsed or progressive multiple myeloma, testing the effectiveness of bortezomib (velcade) as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for breast cancer patients who have received prior chemotherapy with Taxol or Taxotere, and are eligible for treatment with pemetrexed or gemcitabine. The inclusion criteria include having measurable disease and being able to take care of oneself, while the exclusion criteria include pregnancy or breastfeeding, brain metastasis, and previous treatment with gemcitabine or pemetrexed.",
    "This sample is a phase 2 trial for attention-deficit/hyperactivity disorder (ADHD) and includes the drugs abt-089, atomoxetine, and placebo as treatment options, with eligibility criteria including meeting diagnostic criteria for ADHD, being in good health, and weighing at least 37 pounds.",
    "This sample is a phase 2 clinical trial for patients with type 1 diabetes mellitus, testing the drug pramlintide acetate to improve glycemic control in patients already on insulin therapy.",
    "This phase 2 clinical trial is testing the effectiveness of antineoplaston a10 and antineoplaston as2-1 in treating patients with histologically confirmed adenocarcinoma of the esophagus that is unlikely to respond to existing therapy and for which no curative therapy exists. The eligibility criteria include having measurable disease, being 18 years or older, having a Karnofsky performance status of 60-100%, and meeting specific hematopoietic, hepatic, renal, cardiovascular, and pulmonary requirements. Prior concurrent therapies are also taken into consideration.",
    "This sample is a phase 2 clinical trial for patients with non-first episode schizophrenia, testing the effectiveness of the drug MK-8435 (org 25935) at different doses, along with a placebo, in improving negative symptoms as measured by the PANSS scale.",
    "This sample is a phase 2 trial for patients with rheumatoid arthritis, testing the efficacy of the drug mk0812 compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with persistent or intermittent abdominal pain, undergoing elective open abdominal surgery, testing the efficacy of namisol and diazepam/placebo in reducing pain during the surgical procedure.",
    "This sample is a phase 2/phase 3 trial testing the effectiveness of carboplatin plus irinotecan versus carboplatin plus etoposide in treating small cell lung cancer, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 1/phase 2 clinical trial for the treatment of benign prostatic hyperplasia (BPH) using the drugs prx302 and placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2 clinical trial for asthma, testing the effectiveness of levalbuterol hfa mdi followed by racemic albuterol hfa mdi and racemic albuterol followed by levalbuterol hfa mdi in children aged 4 to 11 years, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with metastatic hormone receptor-positive HER2-negative breast cancer, testing the drugs fulvestrant, mk-0646, and dasatinib, with eligibility criteria including prior anti-estrogen therapy and easily accessible tumors for biopsy.",
    "This sample is a phase 2 trial for patients with high-risk hematological malignancies, including leukemia and lymphoma, testing the effectiveness of mycophenolate mofetil, thymoglobulin, and sirolimus as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with non-squamous cell non-small cell lung cancer (NSCLC) in stage IIIA (N2) disease, testing the effectiveness of gemcitabine, cisplatin, bevacizumab, and etoposide as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with breast cancer or ovarian cancer, testing the effectiveness of bevacizumab, fludarabine, melphalan, and thymoglobulin in combination with stem cell transplantation, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with coronary artery disease, testing the use of reg1 and unfractionated heparin drugs in non-urgent elective PCI procedures, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with liver cancer (hepatocellular carcinoma) who have localized, unresectable, or metastatic disease. The trial will test the effectiveness of the drugs everolimus and sorafenib tosylate in treating the disease. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for lung cancer, small cell, testing the drugs topotecan and carboplatin, with eligibility criteria including adequate contraception, absence of active infection, and specific hematologic, renal, and hepatic function requirements.",
    "This sample is a phase 1/phase 2 clinical trial for contraception, testing the effectiveness of levonorgestrel patch in women with specific eligibility criteria and excluding those with contraindications.",
    "This sample is a phase 2 clinical trial for patients with metastatic pancreatic adenocarcinoma, testing the drugs co-1.01 and gemcitabine, with specific inclusion and exclusion criteria for eligibility.",
    "This phase 2 trial is investigating the effectiveness of capecitabine and gemcitabine hydrochloride in treating patients with pancreatic cancer who have either newly diagnosed or previously treated metastatic disease or unresectable disease, and meet specific eligibility criteria.",
    "This sample is a phase 2 trial for the treatment of nonalcoholic steatohepatitis (NASH) using the drugs cystadane and identical placebo, with specific eligibility criteria including abnormal aminotransferase levels, histologic evidence of steatohepatitis, absence of sustained alcohol ingestion, and appropriate exclusion of other liver diseases.",
    "This sample is a phase 2 clinical trial for patients with type 1 diabetes mellitus, testing the effectiveness of various insulin drugs, including insulin lispro, insulin aspart, and insulin glargine, in combination with recombinant human hyaluronidase ph20, to achieve glycemic control.",
    "This sample is a phase 2 trial for patients with stage IV breast cancer, testing the effectiveness of the drugs igf-1r inhibitor osi-906, erlotinib hydrochloride, goserelin, and letrozole, with eligibility criteria including hormone receptor positivity, ECOG performance status 0-1, and various medical conditions and exclusions.",
    "This sample is a phase 2 trial studying the effects of bosentan and placebo on patients with systemic scleroderma and pulmonary hypertension, with specific inclusion and exclusion criteria for participation.",
    "This sample is a phase 2 trial for the drug glyx-13 in patients with major depressive disorder, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic breast cancer, testing the effectiveness of dasatinib, trastuzumab, and paclitaxel as treatment options. The eligibility criteria include having confirmed breast cancer with documented metastasis, HER2 overexpression, and a performance status of 0 or 1. Various previous therapies are allowed, but certain medications and medical conditions are excluded.",
    "This sample is a phase 2 trial investigating the use of inhaled nitric oxide in patients with pulmonary hypertension, lung disease, sickle cell disease, cardiac transplant, or lung transplant, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with allergic rhinitis, testing the drugs sparc1203 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the drugs oxaliplatin, fludarabine, and cytarabine on patients with relapsed or refractory acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome. The eligibility criteria include confirmed diagnosis, specific performance status, and certain levels of serum creatinine, bilirubin, and liver enzymes.",
    "This sample is a phase 2 clinical trial for postmenopausal women with metastatic or locally advanced breast cancer, testing the efficacy of everolimus and fulvestrant as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with chronic graft-versus-host disease (cGVHD) who have not previously been treated with Bortezomib. The study aims to evaluate the effectiveness of Bortezomib in treating steroid-refractory cGVHD. The inclusion criteria include being \u226518 years old, having a diagnosis of steroid-refractory cGVHD, and meeting certain health requirements. The exclusion criteria include having certain medical conditions or receiving other investigational drugs within 14 days before enrollment.",
    "This sample is a phase 2 clinical trial for patients with Huntington's disease and chorea, testing the drugs afq056 and placebo. The inclusion criteria include having a UHDRS maximal chorea score of >10 and stable dosing of concomitant Huntington's medication, while the exclusion criteria include marked cognitive impairment and renal or liver disease.",
    "This phase 2 trial aims to evaluate the efficacy of methylphenidate hydrochloride, a drug used to treat attention deficit hyperactivity disorder (ADHD), in reducing fatigue in patients with prostate cancer who are receiving LHRH-agonist therapy.",
    "This sample is a phase 2/phase 3 trial for patients with non-small cell lung carcinoma, testing the efficacy of 1st line chemotherapy in combination with TG4010 immunotherapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with atrial fibrillation, testing the drugs azd1305 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with mild-to-moderate asthma, testing the effectiveness of various drugs including formoterol fumarate and foradil aerolizer, as well as a placebo, in improving lung function and reducing asthma symptoms. The eligibility criteria include specific requirements for patient demographics, medication use, and spirometry results.",
    "This sample is a phase 2 trial for breast cancer patients at increased risk, testing the effectiveness of tamoxifen citrate in reducing the risk of invasive breast cancer.",
    "This sample is a phase 2 clinical trial for Friedreich's ataxia, testing the drugs lu aa24493 and placebo, with inclusion criteria including a genetic test demonstrating >400 GAA nucleotide triplet repeats and specific sub-scores, and exclusion criteria including disallowed medications, underlying diseases, abnormal vital signs, and recent participation in another clinical trial.",
    "This sample is a phase 2 clinical trial for patients with Waldenstr\u00f6m's macroglobulinemia, testing the drug perifosine. The eligibility criteria include prior therapy for WM, measurable disease, specific laboratory values, and a life expectancy of at least 12 weeks. Exclusion criteria include uncontrolled infection, other active malignancies, and concurrent chemotherapy or investigational therapies.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC) testing the effectiveness of the drug dasatinib. The eligibility criteria include having histological/cytological documented NSCLC, prior treatment with systemic regimens, and adequate organ function. Exclusion criteria include previous or concomitant malignancy, symptomatic pleural effusions, and cardiac symptoms.",
    "This sample is a phase 2 clinical trial for the treatment of gastroparesis using the drugs velusetrag and placebo, with specific eligibility criteria including symptoms of gastroparesis, BMI range, GCSI-2W score, delayed gastric emptying, and ruling out UGI obstruction.",
    "This sample is a phase 2 trial testing the drug akb-6548 in patients with anemia and kidney disease, with specific eligibility criteria including age, chronic kidney disease stage, hemoglobin levels, and exclusion criteria such as BMI, recent blood transfusion, and certain medical conditions.",
    "This sample is a phase 2/phase 3 trial for obesity, with the icd-10 codes E66.8, E66.9, E66.1, O99.214, O99.215, O99.210, and O99.211. The drugs being tested are cp-945,598 and sibutramine, and the eligibility criteria include specific BMI ranges and exclusion criteria for blood pressure, diabetes, eating disorders, and appetite/weight modifying drugs.",
    "This sample is a phase 2 trial for the drug tolvaptan in patients with hyponatremia, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial for HIV infections, testing the drugs enfuvirtide and amdoxovir, with specific eligibility criteria for enrollment.",
    "This sample is a phase 2 clinical trial for patients with breast neoplasms resistant to anthracyclines and taxanes, testing the effectiveness of chemotherapy as a treatment option.",
    "This sample is a phase 2 clinical trial for the treatment of irritable bowel syndrome using the drug rifaximin, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for prostate cancer patients who have completed a previous study and are eligible for endocrine treatment, specifically using the drug degarelix.",
    "This sample is a phase 2 trial testing the effectiveness of ertugliflozin and hctz in participants with type 2 diabetes and hypertension, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with schizophrenia and insomnia related to schizophrenia, testing the drug sodium oxybate, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with stable Coronary Artery Disease, testing the effectiveness of ticagrelor tablets, clopidogrel (over encapsulated) capsule, and aspirin tablets as potential treatments. The inclusion criteria include documented stable Coronary Artery Disease, while the exclusion criteria include a history of Acute Coronary Syndromes within 12 months of screening or the need for revascularization, liver or kidney disease, increased bleeding risk, and intolerance or allergy to Aspirin or clopidogrel.",
    "This sample is a phase 2 trial investigating the use of megestrol acetate, a drug, in pediatric patients with anorexia and weight changes resulting from malignancy, excluding hematological malignancies, who have experienced \u22655% weight loss and are not receiving corticosteroid therapy.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer, testing the drug pazopanib (gw786034) as a treatment option for those who have failed prior chemotherapy regimens. The eligibility criteria include having a confirmed diagnosis of stage IIIB or IV lung cancer, being 18 years or older, and having adequate organ system function.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the effectiveness of a combination of drugs including bortezomib, carmustine, etoposide, cytarabine, and melphalan, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 1/phase 2 trial for idiopathic Parkinson's disease, testing the effects of saline and carbidopa drugs on subjects experiencing motor fluctuations associated with LD/CD dosing, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with Parkinson's disease, testing the drugs piclozotan and 0.9% sodium chloride (normal saline), with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with primary CNS lymphoma, testing the effectiveness of rituxan, cyclophosphamide, etoposide, etoposide phosphate, carboplatin, sodium thiosulfate, neupogen, neulasta, and cytarabine as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for lupus erythematosus, testing the drugs r932333 and placebo, with specific inclusion and exclusion criteria for patients.",
    "This sample is a phase 2 clinical trial for patients with inoperable stage IIIA or IIIB non-small cell lung cancer (NSCLC), testing the effectiveness of carboplatin, gemcitabine hydrochloride, and paclitaxel as treatment options. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 trial for asthma patients, testing the effectiveness of albuterol spiromax, proair hfa, and placebo drugs, with eligibility criteria including age, stable asthma diagnosis, spirometry values, and use of specific medications.",
    "This sample is a phase 2 trial for patients with Philadelphia chromosome positive CML, testing the effectiveness of busulfan, cyclophosphamide, g-csf, and gm-csf drugs in different phases of the disease, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with advanced non-small cell lung cancer, testing the effectiveness of erlotinib, bevacizumab, and standard platinum-based chemotherapy as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of respiratory syncytial virus infections in lung transplant recipients, using the drugs aln-rsv01 and normal saline, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for the treatment of diabetic macular edema using fluocinolone acetonide, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial for patients with non-small cell lung cancer and brain metastases, testing the drug icotinib for those with a positive EGFR mutation, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for untreated B-cell non-Hodgkin's lymphoma, testing the effectiveness of a combination of drugs including cyclophosphamide, etoposide, rituximab, cytarabine, doxorubicin, and tositumomab, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for women with metastatic breast cancer, specifically triple negative breast cancer, testing the efficacy of the drugs rad001 and carboplatin, with eligibility criteria including age, performance status, liver and renal function, and exclusion criteria such as prior treatment with investigational drugs or mTOR inhibitors, uncontrolled medical conditions, and pregnancy.",
    "This sample is a phase 2 clinical trial for patients with advanced clear cell renal carcinoma, testing the drug vandetanib, and includes eligibility criteria such as histological confirmation of the disease, measurable disease, prior therapy requirements, and normal organ and marrow function.",
    "This sample is a phase 2 clinical trial for patients with triple negative metastatic breast cancer, testing the efficacy of gemcitabine and oxaliplatin as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for type 1 diabetes, testing the drugs enalapril and losartan, with specific inclusion and exclusion criteria related to diabetes duration, blood pressure, kidney function, and other chronic diseases or conditions.",
    "This sample is a phase 2 clinical trial for patients with unresectable stage IV melanoma, testing the drugs temozolomide and thalidomide, with eligibility criteria including specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 trial for breast cancer patients, testing the effectiveness of bevacizumab, doxorubicin, cyclophosphamide, capecitabine, and docetaxel drugs, with specific eligibility criteria including disease stage, hepatic and renal function, and cardiac conditions.",
    "This sample is a phase 2 trial for patients with myelodysplastic syndrome (MDS) and includes eligibility criteria such as MDS with </= 10% blasts or IPSS low or intermediate 1, no prior intensive chemotherapy or high-dose ara-C, and adequate liver, renal, and cardiac functions. The study will test the effectiveness of erythropoietin, cyclosporin a, g-csf, and prednisone as potential treatments for MDS.",
    "This sample is a phase 2 clinical trial for the drug laquinimod in patients with relapsing remitting multiple sclerosis, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with recurrent or refractory adult Hodgkin lymphoma, testing the efficacy of vinorelbine tartrate, pegylated liposomal doxorubicin hydrochloride, and gemcitabine hydrochloride as treatment options, with specific eligibility criteria outlined.",
    "This sample is a phase 2/phase 3 trial for patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder, where the drugs being tested are ethyl-eicosapentaenoic acid (epa) and vitamins e + c, and the eligibility criteria include being admitted to a psychiatric hospital within the previous twenty-one days and being between the ages of 18-40.",
    "This sample is a phase 2 trial for patients with transfusional iron overload or transfusional hemosiderosis, testing the effectiveness of various drugs including deferasirox and deferoxamine, with specific eligibility criteria including age, cardiac iron levels, red cell transfusion history, and liver iron content.",
    "This sample is a phase 2 trial for macular degeneration, testing the effectiveness of immune globulin intravenous [human] and albumin (human) 25% in improving visual acuity, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for HIV infection, testing the drug apricitabine, with specific inclusion and exclusion criteria related to previous protocols, HIV RNA levels, CD4 cell count, and pregnancy/breastfeeding status.",
    "This sample is a phase 2 clinical trial for patients with stage III non-small cell lung cancer, testing the effectiveness of chemotherapy following concurrent chemoradiotherapy as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with invasive breast cancer, testing the effectiveness of lapatinib and vinorelbine as a treatment option, with specific eligibility criteria including confirmation of ErbB2 amplification and restrictions on prior treatments.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the drug plitidepsin. The eligibility criteria include written informed consent, age \u2265 18 years, ECOG performance status \u2264 2, life expectancy \u2265 3 months, previous diagnosis of MM, measurable disease, recovery from previous treatments, and specific laboratory values within normal limits. Exclusion criteria include prior therapy with Aplidin\u00ae, pregnancy or lactation, history of other neoplastic diseases, and various relevant diseases or adverse clinical conditions.",
    "This sample is a phase 2/phase 3 trial for patients with end stage renal disease, testing the effectiveness of mycophenolate sodium delayed release tablets and mycophenolate mofetil as immunosuppressive agents for kidney transplantation, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for the treatment of schizophrenia, testing the drugs ly2140023, olanzapine, and placebo, with inclusion criteria requiring participants to meet the DSM-IV criteria for schizophrenia and exclusion criteria including not meeting the full syndromal criteria for other Axis I disorders and not taking any depot antipsychotic within 4 weeks before screening.",
    "This sample is a phase 2 trial for the drug migalastat hcl in treating Fabry disease, a rare genetic disorder, and the eligibility criteria include having a confirmed diagnosis of Fabry disease, end organ dysfunction, and being na\u00efve to enzyme replacement therapy.",
    "This sample is a phase 2 trial testing the drugs ferric citrate and placebo for the treatment of iron deficiency and iron deficiency anemia in patients with stage III to V chronic kidney disease, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC) who have previously been treated with surgery and/or radiotherapy. The trial is testing the drug epothilone d and has specific eligibility criteria for patients, including age, performance status, and various medical conditions.",
    "This sample is a phase 2 trial testing the drugs pf-03187207 and latanoprost vehicle, as well as latanoprost 0.005% and pf-03187207 vehicle, for the treatment of primary open angle glaucoma, ocular hypertension, pigmentary glaucoma, and pseudoexfoliative glaucoma, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for lung cancer patients with extensive stage disease, testing the effectiveness of carboplatin and irinotecan hydrochloride as treatment options. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for the treatment of diabetic macular edema using ranibizumab, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial testing the drug dabigatran etexilate in patients with coronary disease, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with rectal cancer, testing the combination of cetuximab and 5-fluorouracil as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with hemoglobin SC disease, testing the effectiveness of the drug \"mg pidolate\" compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with stable plaque psoriasis, testing the effectiveness of desoximetasone 0.25% spray as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with advanced renal cell carcinoma, testing the effectiveness of two different dosing schedules of sunitinib malate, and includes eligibility criteria such as clear cell histology and measurable disease.",
    "This sample is a phase 2 clinical trial for the drug lbh581 in patients with small cell lung carcinoma, with specific eligibility criteria including prior chemotherapy lines, age range, performance status, and various hematological and organ function requirements.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast cancer, testing the drug imatinib mesylate, and includes eligibility criteria such as prior chemotherapy, measurable lesions, and specific laboratory values.",
    "This sample is a phase 2 clinical trial for asthma patients, testing the effectiveness of drugs such as fp mdpi, flovent diskus, and albuterol/salbutamol in combination with specific eligibility criteria.",
    "This sample is a phase 2 clinical trial for patients with atrial fibrillation, testing the drugs ym150 and warfarin, with specific inclusion and exclusion criteria related to the disease and drug eligibility.",
    "This sample is a phase 2 trial for asthma patients, testing the drugs amg 827 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with medullary thyroid carcinoma, testing the drug sorafenib, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with metastatic breast cancer, testing the drug trastuzumab emtansine (kadcyla) in combination with other therapies, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for lupus nephritis, testing the drug cyclophosphamide, and includes eligibility criteria such as age, SLE diagnosis, and lupus nephritis classification.",
    "This sample is a phase 2 trial for patients with metastatic or unresectable kidney cancer, testing the drug sorafenib, with specific eligibility criteria including histologically confirmed renal cell carcinoma and no evidence of CNS metastases.",
    "This sample is a phase 1/phase 2 clinical trial for patients with various types of indolent B-cell non-Hodgkin lymphoma, testing the effectiveness of bendamustine hydrochloride and obatoclax mesylate drugs, with specific eligibility criteria including prior therapy, performance status, blood counts, liver and kidney function, and exclusion of certain medical conditions.",
    "This sample is a phase 1/phase 2 trial for patients with non-small-cell lung carcinoma, testing the efficacy of pemetrexed, carboplatin, and sorafenib compared to pemetrexed, carboplatin, and placebo, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for diabetic macular edema, testing the effectiveness of dexamethasone and sham injection as treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for the treatment of Clostridium difficile infection, testing the effectiveness of drugs such as cadazolid and vancomycin, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with unresectable gallbladder or bile duct carcinoma, testing the effectiveness of irinotecan hydrochloride as a treatment option. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 1/phase 2 trial for patients with chronic obstructive pulmonary disease (COPD), testing the drugs glycopyrrolate, tiotropium, and placebo. The inclusion criteria include age, informed consent, COPD diagnosis, smoking history, lung function measurements, and airway reversibility. The exclusion criteria include allergies, blood eosinophil count, abnormal physical examination and ECG parameters, significant diseases unrelated to COPD, recent respiratory tract infection, oxygen therapy, other lung diseases, intolerance or hypersensitivity to treatment, history of alcohol or substance abuse, recent corticosteroid or tiotropium use, and pregnancy or lactation.",
    "This sample is a phase 2 trial for the drug GSK1521498 and placebo in obese individuals, with eligibility criteria including a BMI greater than or equal to 30 kg/m2 and a Binge Eating Scale score greater than or equal to 19.",
    "This sample is a phase 1/phase 2 trial for the treatment of chronic hepatitis C, testing the drugs idx719 and placebo, with inclusion criteria including documented GT1, GT2, or GT3 chronic HCV infection, and exclusion criteria including prior HCV treatment and co-infection with hepatitis B virus (HBV) and/or human immunodeficiency virus (HIV).",
    "This sample is a phase 2 trial testing the drug rabeprazole for the treatment of functional dyspepsia, with specific inclusion and exclusion criteria.",
    "This phase 2 trial aims to evaluate the efficacy of docetaxel, cisplatin, 5-fu, cetuximab, and carboplatin in treating squamous cell carcinoma of the head and neck, specifically in patients with HPV 16 positive oropharyngeal or unknown primary tumors, with stage 3 or 4 disease and no evidence of distant metastases, and who meet other eligibility criteria.",
    "This sample is a phase 2 trial for patients with type 1 diabetes mellitus, testing the efficacy of dapagliflozin and placebo in reducing A1C levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the drugs busulfan, fludarabine phosphate, methotrexate, and tacrolimus for the treatment of various myeloid malignancies, including chronic myeloproliferative disorders, graft versus host disease, leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases. The eligibility criteria include having a matched related or unrelated donor available and meeting certain patient characteristics such as no severe life-limiting diseases and meeting specific laboratory values.",
    "This sample is a phase 2 clinical trial for patients with unresectable and/or metastatic clear cell renal cell carcinoma (RCC). The drug being tested is regorafenib (Stivarga) and the eligibility criteria include having measurable lesions, low or intermediate risk per the Motzer score, and an Eastern Co-operative Oncology Group (ECOG) performance status of 0 or 1.",
    "This sample is a phase 2 clinical trial for patients with recurrent small cell lung cancer, testing the effectiveness of 13-cis-retinoic acid and paclitaxel as treatment options, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for the treatment of chronic hepatitis C. The trial includes the drugs vaniprevir, pegylated interferon, ribavirin, and placebo, and has specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the efficacy of different doses of taspoglutide and a placebo, with specific inclusion and exclusion criteria."
]